Compensatory Excretion of Prostacyclin and Thromboxane Metabolites in Obstructive Sleep Apnea Syndrome

Internal Medicine

Volumn 37, Issue 2, 1998, Pages 127-133

  Kimura, Hiroshi ^a   Niijima, Mafumi ^a   Abe, Yuzo ^a   Edo, Hidenori ^a   Sakabe, Hideo ^a   Kojima, Akio ^a   Hasako, Kiyoshi ^a   Masuyama, Shigeru ^a   Tatsumi, Koichiro ^a   Kuriyama, Takayuki ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Arterial blood pressure; Continuous positive airway pressure; Hypertension; Prostanoids; Upper airway

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; OXYGEN; THROMBOXANE B2;

ADULT; ARTICLE; BLOOD; BLOOD PRESSURE; CASE CONTROL STUDY; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; SLEEP APNEA SYNDROME; URINE;

6-KETOPROSTAGLANDIN F1 ALPHA; ADULT; BLOOD PRESSURE; CASE-CONTROL STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OXYGEN; POSITIVE-PRESSURE RESPIRATION; SLEEP APNEA SYNDROMES; THROMBOXANE B2;

EID: 0031989376     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.37.127     Document Type: Article

References (32)

1. Barst RJ, Stalcup SA, Steeg CN, et al. Relation of arachidonate metabolites to abnormal control of the pulmonary circulation in a child. Am Rev Respir Dis 131: 171, 1985.
2. Montalescot G, Lowenstein E, Ogletree ML, et al. Thromboxane receptor blockade prevents pulmonary hypertension induced by heparin-protamine reactions in awake sheep. Circulation 82: 1765, 1990.
3. Christman BW, McPherson CD, Newman JH, et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 327: 70, 1992.
4. Stewart DJ. Endothelial dysfunction in pulmonary vascular disorders. Arzneimittel-Forschung 44: 451, 1994.
5. 2. J Appl Physiol 80: 191, 1996.
6. Hoffstein V, Chan CK, Slutsky AS. Sleep apnea and systemic hypertension: a causal association review. Am J Med 91: 190, 1991.
7. Millman RP, Redline S, Carlisle CC, Assaf AR, Levinson PD. Daytime hypertension in obstructive sleep apnea. Prevalence and contributing risk factors. Chest 99: 861, 1991.
8. Podszus T, Greenberg H, Scharf SM. Influence of sleep state and sleep-disordered breathing on cardiovascular function, in: Sleep and breathing. Second edition, revised and expanded, Saunders NA, Sullivan CE, Eds. Marcel Dekker, New York, 1994, p. 257.
9. Grone HJ, Grippo RS, Arendshorst WJ, Dunn MJ. Role of thromboxane in control of arterial pressure and renal function in young spontaneously hypertensive rats. Am J Physiol 250: F488, 1986.
10. 2 and development of genetic hypertension in the Lyon rat strain. Hypertension 16: 655, 1990.
11. Weitzenblum E, Krieger J, Apprill M, et al. Daytime pulmonary hyper- tension in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis 138: 345, 1988.
12. Chaouat A, Weitzenblum E, Krieger J, Oswald M, Kessler R. Pulmonary hemodynamics in the obstructive sleep apnea syndrome. Results in 220 consecutive patients. Chest 109: 380, 1996.
13. Fletcher EC, DeBehnke RD, Lovoi MS, Gorin AB. Undiagnosed sleep apnea in patients with essential hypertension. Ann Intern Med 103: 190, 1985.
14. 1 alpha: normal values in adults. Clin Chim Acta 126: 283, 1982.
15. 2 with prior purification by high performance liquid chromatography. Prostaglandins Leukot Med 18: 393, 1985.
16. Micieli G, Manni R, Tassorelli C, Osipova V, Tartara A, Nappi G. Sleepapnoea and autonomic dysfunction: a cardiopressor and pupillometric study. Acta Neurol Scand 91: 382, 1995.
17. Lugaresi E, Coccagna G, Mantovani M, Cirignotta F, Ambrosetto G, Baturic P. Hypersomnia with periodic breathing: periodic apneas and alveolar hypoventilalion during sleep. Bull Physiopathol Respir 8: 1103, 1972.
18. Watanabe T, Mano T, Iwase S, et al. Enhanced muscle sympathetic nerve activity during sleep apnea in the elderly. J Auton Nerv Syst 37: 223, 1992.
19. Somers VK, Dyken ME, Mark AL, Abboud FM. Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med 328: 303, 1993.
20. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96: 1897, 1995.
21. Krieger J, Benzoni D, Sforza E, Sassard J. Urinary excretion of prostanoids during sleep in obstructive sleep apnoea patients. Clin Exp Pharmacol Physiol 18: 551, 1991.
22. Sullivan CE, Issa EG, Berthon-Jones M, Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1: 862, 1981.
23. Ali NJ, Davies RJ, Fleetham JA, Stradling JR. The acute effects of continuous positive airway pressure and oxygen administration on blood pressure during obstructive sleep apnea. Chest 101: 1526, 1992.
24. Krieger J, Sforza E, Barthelmebs M, Imbs JL, Kurtz D. Overnight decrease in hematocrit after nasal CPAP treatment in patients with OSA. Chest 97: 729, 1990.
25. 2 in the aged kidney. Prostaglandins Leukot Med 16: 347, 1984.
26. Cohen DJ, Loertscher R, Rubin MF, Tilney NL, Carpenter CB, Strom TB. Cyclosporine: A new immunosuppressive agent for organ transplantation. Ann Intern Med 101: 667, 1984.
27. Vanrenterghem Y, Roels L, Lerut T, et al. Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients. Lancet 1: 999, 1985.
28. 2 to prostacyclin in association with increased blood pressure in patients on cyclosporine A. Prostaglandins 37: 567, 1989.
29. Luscher TF, Diederich D, Buhler FR, Vanhoutte PM. Interactions between platelets and the vessel wall. Role of endothelium-derived vasoactive substances. in: Hypertension: Pathophysiology, diagnosis, and management, Laragh JH, Brenner BM, Eds. Raven Press, New York, 1990, p. 637.
30. Luscher TF. Imbalance of endothelium-derived relaxing and contracting factors. A new concept in hypertension? Am J Hypertens 3: 317, 1990.
31. 2 in Dahl genetical strain susceptible to salt-induced hypertension. Prostaglandins 33: 727, 1987.
32. 2synthase to vascular prostacyclin production in Dahl rats susceptible to salt-induced hypertension. Am J Hypertens 3: 313, 1990.